Subscriptions make life easier, but the convenience can come at a cost

New Delhi, Sept. 8 -- What was once a routine schedule of grocery runs, trips to the pharmacy, visits to the tailor or drop-ins at the gym is increasingly being replaced by frictionless, digital-first... Read More

Odisha to pay 7 per cent interest on delayed pension payments due to administrative lapses

Bhubaneswar, Sept. 8 -- Odisha Cabinet took a major decision to provide annual interest of 7 per cent if pension payments are delayed due to administrative negligence. The government amended the Odish... Read More

'Fictional, loose figment of irrational tit-bits': SBI report refutes claims of missing nominal GDP data

New Delhi, Sept. 8 -- The narrative surrounding the supposed missing sums in the national accounts is a badly scripted piece of fiction devoid of any logic, according to the latest research report fro... Read More

List of Telangana voters who received SIR notices out, Hyderabad tops

Hyderabad, Sept. 8 -- Telangana Chief Electoral Officer (CEO) C Sudharsan Reddy has released the list of voters who received notices under the Special Intensive Revision (SIR) of electoral rolls, whic... Read More

Mother, 11-month-old son killed in Dinajpur road crash

Dinajpur, Sept. 8 -- month-old son were killed when a truck hit the motorcycle they were riding in Birampur upazila of Dinajpur on Tuesday. The deceased were identified as Rumi Akhter, 22, wife of Ma... Read More

Danjuma Foundation offers 50 Taraba children specialist eye care

Nigeria, Sept. 8 -- The T.Y. Danjuma Foundation has sent 50 children from Murbai in Ardo-Kola Local Government Area of Taraba State for specialist treatment after they developed eye problems. The chi... Read More

Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Effect of Muvalaplin on the Reduction of Major Adverse Cardiovascular Events in Adults with Elevated Lipoprotein(a) Who Have Had a Prior Atherosclerotic Cardiovascular Event or Are at Risk for a First Atherosclerotic Cardiovascular Event – MOVE-Lp(a)

Singapore, Sept. 8 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Effect of Muvala... Read More

Singapore Clinical Trial: FRAmework-01: A Three-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) versus Chemotherapy or Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer, and Sofetabart Mipitecan plus Bevacizumab versus Platinum-Based Chemotherapy plus Bevacizumab in Platinum-Sensitive Ovarian Cancer

Singapore, Sept. 8 -- The Health Sciences Authority received information related to the study titled 'FRAmework-01: A Three-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) versus Chemotherapy o... Read More

Singapore Clinical Trial: A Randomized, Open-Label, Phase 3 Study of Rinatabart Sesutecan (Rina-S) Plus Standard of Care Versus Standard of Care as Maintenance Treatment After 2L Platinum-Based Doublet Chemotherapy in Participants With Recurrent Platinum- Sensitive Ovarian Cancer (PSOC)

Singapore, Sept. 8 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Open-Label, Phase 3 Study of Rinatabart Sesutecan (Rina-S) Plus Standard of Care Ver... Read More

Singapore Clinical Trial: An Open-label, Randomized, Controlled Phase 3 Study of Disitamab Vedotin in Combination with Pembrolizumab Versus Chemotherapy in Subjects with Previously Untreated Locally Advanced or Metastatic Urothelial Carcinoma that Expresses HER2 (IHC 1+ and Greater)

Singapore, Sept. 8 -- The Health Sciences Authority received information related to the study titled 'An Open-label, Randomized, Controlled Phase 3 Study of Disitamab Vedotin in Combination with Pembr... Read More

• ««
• «
• 922
• 923
• 924
• 925
• 926
• 927
• 928
• 929
• 930
• 931
• »
• »»